symbol,statement_type,period_end,line_item,value
POLYMED.NS,income,2025-03-31 00:00:00,Tax Effect Of Unusual Items,0.0
POLYMED.NS,income,2025-03-31 00:00:00,Tax Rate For Calcs,0.251832
POLYMED.NS,income,2025-03-31 00:00:00,Normalized EBITDA,5476938000.0
POLYMED.NS,income,2025-03-31 00:00:00,Total Unusual Items,0.0
POLYMED.NS,income,2025-03-31 00:00:00,Total Unusual Items Excluding Goodwill,0.0
POLYMED.NS,income,2025-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,3385572000.0
POLYMED.NS,income,2025-03-31 00:00:00,Reconciled Depreciation,831822000.0
POLYMED.NS,income,2025-03-31 00:00:00,Reconciled Cost Of Revenue,5546902000.0
POLYMED.NS,income,2025-03-31 00:00:00,EBITDA,5476938000.0
POLYMED.NS,income,2025-03-31 00:00:00,EBIT,4645116000.0
POLYMED.NS,income,2025-03-31 00:00:00,Net Interest Income,-119965000.0
POLYMED.NS,income,2025-03-31 00:00:00,Interest Expense,119965000.0
POLYMED.NS,income,2025-03-31 00:00:00,Interest Income,
POLYMED.NS,income,2025-03-31 00:00:00,Normalized Income,3385572000.0
POLYMED.NS,income,2025-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,3385572000.0
POLYMED.NS,income,2025-03-31 00:00:00,Total Expenses,12996277000.0
POLYMED.NS,income,2025-03-31 00:00:00,Rent Expense Supplemental,
POLYMED.NS,income,2025-03-31 00:00:00,Diluted Average Shares,
POLYMED.NS,income,2025-03-31 00:00:00,Basic Average Shares,
POLYMED.NS,income,2025-03-31 00:00:00,Diluted EPS,
POLYMED.NS,income,2025-03-31 00:00:00,Basic EPS,
POLYMED.NS,income,2025-03-31 00:00:00,Diluted NI Availto Com Stockholders,3385572000.0
POLYMED.NS,income,2025-03-31 00:00:00,Net Income Common Stockholders,3385572000.0
POLYMED.NS,income,2025-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
POLYMED.NS,income,2025-03-31 00:00:00,Net Income,3385572000.0
POLYMED.NS,income,2025-03-31 00:00:00,Minority Interests,
POLYMED.NS,income,2025-03-31 00:00:00,Net Income Including Noncontrolling Interests,3385572000.0
POLYMED.NS,income,2025-03-31 00:00:00,Net Income Continuous Operations,3385572000.0
POLYMED.NS,income,2025-03-31 00:00:00,Tax Provision,1139579000.0
POLYMED.NS,income,2025-03-31 00:00:00,Pretax Income,4525151000.0
POLYMED.NS,income,2025-03-31 00:00:00,Other Non Operating Income Expenses,891276000.0
POLYMED.NS,income,2025-03-31 00:00:00,Special Income Charges,0.0
POLYMED.NS,income,2025-03-31 00:00:00,Other Special Charges,
POLYMED.NS,income,2025-03-31 00:00:00,Write Off,
POLYMED.NS,income,2025-03-31 00:00:00,Net Non Operating Interest Income Expense,-119965000.0
POLYMED.NS,income,2025-03-31 00:00:00,Total Other Finance Cost,
POLYMED.NS,income,2025-03-31 00:00:00,Interest Expense Non Operating,119965000.0
POLYMED.NS,income,2025-03-31 00:00:00,Interest Income Non Operating,
POLYMED.NS,income,2025-03-31 00:00:00,Operating Income,3702039000.0
POLYMED.NS,income,2025-03-31 00:00:00,Operating Expense,7449375000.0
POLYMED.NS,income,2025-03-31 00:00:00,Other Operating Expenses,3361984000.0
POLYMED.NS,income,2025-03-31 00:00:00,Depreciation And Amortization In Income Statement,826360000.0
POLYMED.NS,income,2025-03-31 00:00:00,Amortization,
POLYMED.NS,income,2025-03-31 00:00:00,Depreciation Income Statement,826360000.0
POLYMED.NS,income,2025-03-31 00:00:00,Research And Development,245711000.0
POLYMED.NS,income,2025-03-31 00:00:00,Selling General And Administration,
POLYMED.NS,income,2025-03-31 00:00:00,Selling And Marketing Expense,
POLYMED.NS,income,2025-03-31 00:00:00,General And Administrative Expense,
POLYMED.NS,income,2025-03-31 00:00:00,Rent And Landing Fees,
POLYMED.NS,income,2025-03-31 00:00:00,Gross Profit,11151414000.0
POLYMED.NS,income,2025-03-31 00:00:00,Cost Of Revenue,5546902000.0
POLYMED.NS,income,2025-03-31 00:00:00,Total Revenue,16698316000.0
POLYMED.NS,income,2025-03-31 00:00:00,Operating Revenue,16698316000.0
POLYMED.NS,income,2024-03-31 00:00:00,Tax Effect Of Unusual Items,0.0
POLYMED.NS,income,2024-03-31 00:00:00,Tax Rate For Calcs,0.249832
POLYMED.NS,income,2024-03-31 00:00:00,Normalized EBITDA,4194965000.0
POLYMED.NS,income,2024-03-31 00:00:00,Total Unusual Items,0.0
POLYMED.NS,income,2024-03-31 00:00:00,Total Unusual Items Excluding Goodwill,0.0
POLYMED.NS,income,2024-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,2582597000.0
POLYMED.NS,income,2024-03-31 00:00:00,Reconciled Depreciation,639265000.0
POLYMED.NS,income,2024-03-31 00:00:00,Reconciled Cost Of Revenue,4826076000.0
POLYMED.NS,income,2024-03-31 00:00:00,EBITDA,4194965000.0
POLYMED.NS,income,2024-03-31 00:00:00,EBIT,3555700000.0
POLYMED.NS,income,2024-03-31 00:00:00,Net Interest Income,-113009000.0
POLYMED.NS,income,2024-03-31 00:00:00,Interest Expense,113009000.0
POLYMED.NS,income,2024-03-31 00:00:00,Interest Income,118356000.0
POLYMED.NS,income,2024-03-31 00:00:00,Normalized Income,2582597000.0
POLYMED.NS,income,2024-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,2582597000.0
POLYMED.NS,income,2024-03-31 00:00:00,Total Expenses,10815012000.0
POLYMED.NS,income,2024-03-31 00:00:00,Rent Expense Supplemental,22265000.0
POLYMED.NS,income,2024-03-31 00:00:00,Diluted Average Shares,96007323.0
POLYMED.NS,income,2024-03-31 00:00:00,Basic Average Shares,95935996.0
POLYMED.NS,income,2024-03-31 00:00:00,Diluted EPS,26.9
POLYMED.NS,income,2024-03-31 00:00:00,Basic EPS,26.92
POLYMED.NS,income,2024-03-31 00:00:00,Diluted NI Availto Com Stockholders,2582597000.0
POLYMED.NS,income,2024-03-31 00:00:00,Net Income Common Stockholders,2582597000.0
POLYMED.NS,income,2024-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
POLYMED.NS,income,2024-03-31 00:00:00,Net Income,2582597000.0
POLYMED.NS,income,2024-03-31 00:00:00,Minority Interests,0.0
POLYMED.NS,income,2024-03-31 00:00:00,Net Income Including Noncontrolling Interests,2582597000.0
POLYMED.NS,income,2024-03-31 00:00:00,Net Income Continuous Operations,2582597000.0
POLYMED.NS,income,2024-03-31 00:00:00,Tax Provision,860094000.0
POLYMED.NS,income,2024-03-31 00:00:00,Pretax Income,3442691000.0
POLYMED.NS,income,2024-03-31 00:00:00,Other Non Operating Income Expenses,587481000.0
POLYMED.NS,income,2024-03-31 00:00:00,Special Income Charges,0.0
POLYMED.NS,income,2024-03-31 00:00:00,Other Special Charges,-6228000.0
POLYMED.NS,income,2024-03-31 00:00:00,Write Off,11827000.0
POLYMED.NS,income,2024-03-31 00:00:00,Net Non Operating Interest Income Expense,-113009000.0
POLYMED.NS,income,2024-03-31 00:00:00,Total Other Finance Cost,28647000.0
POLYMED.NS,income,2024-03-31 00:00:00,Interest Expense Non Operating,113009000.0
POLYMED.NS,income,2024-03-31 00:00:00,Interest Income Non Operating,118356000.0
POLYMED.NS,income,2024-03-31 00:00:00,Operating Income,2942951000.0
POLYMED.NS,income,2024-03-31 00:00:00,Operating Expense,5988936000.0
POLYMED.NS,income,2024-03-31 00:00:00,Other Operating Expenses,2700952000.0
POLYMED.NS,income,2024-03-31 00:00:00,Depreciation And Amortization In Income Statement,634444000.0
POLYMED.NS,income,2024-03-31 00:00:00,Amortization,34911000.0
POLYMED.NS,income,2024-03-31 00:00:00,Depreciation Income Statement,634444000.0
POLYMED.NS,income,2024-03-31 00:00:00,Research And Development,194423000.0
POLYMED.NS,income,2024-03-31 00:00:00,Selling General And Administration,473246000.0
POLYMED.NS,income,2024-03-31 00:00:00,Selling And Marketing Expense,263654000.0
POLYMED.NS,income,2024-03-31 00:00:00,General And Administrative Expense,209592000.0
POLYMED.NS,income,2024-03-31 00:00:00,Rent And Landing Fees,22265000.0
POLYMED.NS,income,2024-03-31 00:00:00,Gross Profit,8931887000.0
POLYMED.NS,income,2024-03-31 00:00:00,Cost Of Revenue,4826076000.0
POLYMED.NS,income,2024-03-31 00:00:00,Total Revenue,13757963000.0
POLYMED.NS,income,2024-03-31 00:00:00,Operating Revenue,13757963000.0
POLYMED.NS,income,2023-03-31 00:00:00,Tax Effect Of Unusual Items,-10004584.8
POLYMED.NS,income,2023-03-31 00:00:00,Tax Rate For Calcs,0.2471
POLYMED.NS,income,2023-03-31 00:00:00,Normalized EBITDA,3072501000.0
POLYMED.NS,income,2023-03-31 00:00:00,Total Unusual Items,-40488000.0
POLYMED.NS,income,2023-03-31 00:00:00,Total Unusual Items Excluding Goodwill,-40488000.0
POLYMED.NS,income,2023-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,1792825000.0
POLYMED.NS,income,2023-03-31 00:00:00,Reconciled Depreciation,571668000.0
POLYMED.NS,income,2023-03-31 00:00:00,Reconciled Cost Of Revenue,5093215000.0
POLYMED.NS,income,2023-03-31 00:00:00,EBITDA,3032013000.0
POLYMED.NS,income,2023-03-31 00:00:00,EBIT,2460345000.0
POLYMED.NS,income,2023-03-31 00:00:00,Net Interest Income,-48834000.0
POLYMED.NS,income,2023-03-31 00:00:00,Interest Expense,85431000.0
POLYMED.NS,income,2023-03-31 00:00:00,Interest Income,59740000.0
POLYMED.NS,income,2023-03-31 00:00:00,Normalized Income,1823308415.2
POLYMED.NS,income,2023-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,1792825000.0
POLYMED.NS,income,2023-03-31 00:00:00,Total Expenses,8908082000.0
POLYMED.NS,income,2023-03-31 00:00:00,Rent Expense Supplemental,19296000.0
POLYMED.NS,income,2023-03-31 00:00:00,Diluted Average Shares,96020945.0
POLYMED.NS,income,2023-03-31 00:00:00,Basic Average Shares,95916495.0
POLYMED.NS,income,2023-03-31 00:00:00,Diluted EPS,18.67
POLYMED.NS,income,2023-03-31 00:00:00,Basic EPS,18.69
POLYMED.NS,income,2023-03-31 00:00:00,Diluted NI Availto Com Stockholders,1792825000.0
POLYMED.NS,income,2023-03-31 00:00:00,Net Income Common Stockholders,1792825000.0
POLYMED.NS,income,2023-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
POLYMED.NS,income,2023-03-31 00:00:00,Net Income,1792825000.0
POLYMED.NS,income,2023-03-31 00:00:00,Minority Interests,0.0
POLYMED.NS,income,2023-03-31 00:00:00,Net Income Including Noncontrolling Interests,1792825000.0
POLYMED.NS,income,2023-03-31 00:00:00,Net Income Continuous Operations,1792825000.0
POLYMED.NS,income,2023-03-31 00:00:00,Tax Provision,582089000.0
POLYMED.NS,income,2023-03-31 00:00:00,Pretax Income,2374914000.0
POLYMED.NS,income,2023-03-31 00:00:00,Other Non Operating Income Expenses,32976000.0
POLYMED.NS,income,2023-03-31 00:00:00,Special Income Charges,-419000.0
POLYMED.NS,income,2023-03-31 00:00:00,Other Special Charges,-1003000.0
POLYMED.NS,income,2023-03-31 00:00:00,Write Off,1422000.0
POLYMED.NS,income,2023-03-31 00:00:00,Net Non Operating Interest Income Expense,-48834000.0
POLYMED.NS,income,2023-03-31 00:00:00,Total Other Finance Cost,23143000.0
POLYMED.NS,income,2023-03-31 00:00:00,Interest Expense Non Operating,85431000.0
POLYMED.NS,income,2023-03-31 00:00:00,Interest Income Non Operating,59740000.0
POLYMED.NS,income,2023-03-31 00:00:00,Operating Income,2178500000.0
POLYMED.NS,income,2023-03-31 00:00:00,Operating Expense,3814867000.0
POLYMED.NS,income,2023-03-31 00:00:00,Other Operating Expenses,721760000.0
POLYMED.NS,income,2023-03-31 00:00:00,Depreciation And Amortization In Income Statement,571668000.0
POLYMED.NS,income,2023-03-31 00:00:00,Amortization,29194000.0
POLYMED.NS,income,2023-03-31 00:00:00,Depreciation Income Statement,542474000.0
POLYMED.NS,income,2023-03-31 00:00:00,Research And Development,178025000.0
POLYMED.NS,income,2023-03-31 00:00:00,Selling General And Administration,380851000.0
POLYMED.NS,income,2023-03-31 00:00:00,Selling And Marketing Expense,205118000.0
POLYMED.NS,income,2023-03-31 00:00:00,General And Administrative Expense,175733000.0
POLYMED.NS,income,2023-03-31 00:00:00,Rent And Landing Fees,19296000.0
POLYMED.NS,income,2023-03-31 00:00:00,Gross Profit,5993367000.0
POLYMED.NS,income,2023-03-31 00:00:00,Cost Of Revenue,5093215000.0
POLYMED.NS,income,2023-03-31 00:00:00,Total Revenue,11086582000.0
POLYMED.NS,income,2023-03-31 00:00:00,Operating Revenue,11086582000.0
POLYMED.NS,income,2022-03-31 00:00:00,Tax Effect Of Unusual Items,23940665.6
POLYMED.NS,income,2022-03-31 00:00:00,Tax Rate For Calcs,0.2528
POLYMED.NS,income,2022-03-31 00:00:00,Normalized EBITDA,2434507000.0
POLYMED.NS,income,2022-03-31 00:00:00,Total Unusual Items,94702000.0
POLYMED.NS,income,2022-03-31 00:00:00,Total Unusual Items Excluding Goodwill,94702000.0
POLYMED.NS,income,2022-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,1465060000.0
POLYMED.NS,income,2022-03-31 00:00:00,Reconciled Depreciation,539522000.0
POLYMED.NS,income,2022-03-31 00:00:00,Reconciled Cost Of Revenue,4332255000.0
POLYMED.NS,income,2022-03-31 00:00:00,EBITDA,2529209000.0
POLYMED.NS,income,2022-03-31 00:00:00,EBIT,1989687000.0
POLYMED.NS,income,2022-03-31 00:00:00,Net Interest Income,-38722000.0
POLYMED.NS,income,2022-03-31 00:00:00,Interest Expense,37238000.0
POLYMED.NS,income,2022-03-31 00:00:00,Interest Income,22913000.0
POLYMED.NS,income,2022-03-31 00:00:00,Normalized Income,1394298665.6
POLYMED.NS,income,2022-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,1465060000.0
POLYMED.NS,income,2022-03-31 00:00:00,Total Expenses,7528345000.0
POLYMED.NS,income,2022-03-31 00:00:00,Rent Expense Supplemental,22357000.0
POLYMED.NS,income,2022-03-31 00:00:00,Diluted Average Shares,95964194.0
POLYMED.NS,income,2022-03-31 00:00:00,Basic Average Shares,95888694.0
POLYMED.NS,income,2022-03-31 00:00:00,Diluted EPS,15.27
POLYMED.NS,income,2022-03-31 00:00:00,Basic EPS,15.28
POLYMED.NS,income,2022-03-31 00:00:00,Diluted NI Availto Com Stockholders,1465060000.0
POLYMED.NS,income,2022-03-31 00:00:00,Net Income Common Stockholders,1465060000.0
POLYMED.NS,income,2022-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
POLYMED.NS,income,2022-03-31 00:00:00,Net Income,1465060000.0
POLYMED.NS,income,2022-03-31 00:00:00,Minority Interests,0.0
POLYMED.NS,income,2022-03-31 00:00:00,Net Income Including Noncontrolling Interests,1465060000.0
POLYMED.NS,income,2022-03-31 00:00:00,Net Income Continuous Operations,1465060000.0
POLYMED.NS,income,2022-03-31 00:00:00,Tax Provision,487389000.0
POLYMED.NS,income,2022-03-31 00:00:00,Pretax Income,1952449000.0
POLYMED.NS,income,2022-03-31 00:00:00,Other Non Operating Income Expenses,36518000.0
POLYMED.NS,income,2022-03-31 00:00:00,Special Income Charges,-1301000.0
POLYMED.NS,income,2022-03-31 00:00:00,Other Special Charges,-5305000.0
POLYMED.NS,income,2022-03-31 00:00:00,Write Off,6606000.0
POLYMED.NS,income,2022-03-31 00:00:00,Net Non Operating Interest Income Expense,-38722000.0
POLYMED.NS,income,2022-03-31 00:00:00,Total Other Finance Cost,24397000.0
POLYMED.NS,income,2022-03-31 00:00:00,Interest Expense Non Operating,37238000.0
POLYMED.NS,income,2022-03-31 00:00:00,Interest Income Non Operating,22913000.0
POLYMED.NS,income,2022-03-31 00:00:00,Operating Income,1640534000.0
POLYMED.NS,income,2022-03-31 00:00:00,Operating Expense,3196090000.0
POLYMED.NS,income,2022-03-31 00:00:00,Other Operating Expenses,559930000.0
POLYMED.NS,income,2022-03-31 00:00:00,Depreciation And Amortization In Income Statement,539522000.0
POLYMED.NS,income,2022-03-31 00:00:00,Amortization,26784000.0
POLYMED.NS,income,2022-03-31 00:00:00,Depreciation Income Statement,512738000.0
POLYMED.NS,income,2022-03-31 00:00:00,Research And Development,187711000.0
POLYMED.NS,income,2022-03-31 00:00:00,Selling General And Administration,322396000.0
POLYMED.NS,income,2022-03-31 00:00:00,Selling And Marketing Expense,150766000.0
POLYMED.NS,income,2022-03-31 00:00:00,General And Administrative Expense,171630000.0
POLYMED.NS,income,2022-03-31 00:00:00,Rent And Landing Fees,22357000.0
POLYMED.NS,income,2022-03-31 00:00:00,Gross Profit,4836624000.0
POLYMED.NS,income,2022-03-31 00:00:00,Cost Of Revenue,4332255000.0
POLYMED.NS,income,2022-03-31 00:00:00,Total Revenue,9168879000.0
POLYMED.NS,income,2022-03-31 00:00:00,Operating Revenue,9168879000.0
POLYMED.NS,income,2021-03-31 00:00:00,Tax Effect Of Unusual Items,
POLYMED.NS,income,2021-03-31 00:00:00,Tax Rate For Calcs,
POLYMED.NS,income,2021-03-31 00:00:00,Normalized EBITDA,
POLYMED.NS,income,2021-03-31 00:00:00,Total Unusual Items,
POLYMED.NS,income,2021-03-31 00:00:00,Total Unusual Items Excluding Goodwill,
POLYMED.NS,income,2021-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,
POLYMED.NS,income,2021-03-31 00:00:00,Reconciled Depreciation,
POLYMED.NS,income,2021-03-31 00:00:00,Reconciled Cost Of Revenue,
POLYMED.NS,income,2021-03-31 00:00:00,EBITDA,
POLYMED.NS,income,2021-03-31 00:00:00,EBIT,
POLYMED.NS,income,2021-03-31 00:00:00,Net Interest Income,
POLYMED.NS,income,2021-03-31 00:00:00,Interest Expense,
POLYMED.NS,income,2021-03-31 00:00:00,Interest Income,33726000.0
POLYMED.NS,income,2021-03-31 00:00:00,Normalized Income,
POLYMED.NS,income,2021-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,
POLYMED.NS,income,2021-03-31 00:00:00,Total Expenses,
POLYMED.NS,income,2021-03-31 00:00:00,Rent Expense Supplemental,22191000.0
POLYMED.NS,income,2021-03-31 00:00:00,Diluted Average Shares,89155423.0
POLYMED.NS,income,2021-03-31 00:00:00,Basic Average Shares,89083537.0
POLYMED.NS,income,2021-03-31 00:00:00,Diluted EPS,15.24
POLYMED.NS,income,2021-03-31 00:00:00,Basic EPS,15.25
POLYMED.NS,income,2021-03-31 00:00:00,Diluted NI Availto Com Stockholders,
POLYMED.NS,income,2021-03-31 00:00:00,Net Income Common Stockholders,
POLYMED.NS,income,2021-03-31 00:00:00,Otherunder Preferred Stock Dividend,
POLYMED.NS,income,2021-03-31 00:00:00,Net Income,
POLYMED.NS,income,2021-03-31 00:00:00,Minority Interests,0.0
POLYMED.NS,income,2021-03-31 00:00:00,Net Income Including Noncontrolling Interests,
POLYMED.NS,income,2021-03-31 00:00:00,Net Income Continuous Operations,
POLYMED.NS,income,2021-03-31 00:00:00,Tax Provision,
POLYMED.NS,income,2021-03-31 00:00:00,Pretax Income,
POLYMED.NS,income,2021-03-31 00:00:00,Other Non Operating Income Expenses,
POLYMED.NS,income,2021-03-31 00:00:00,Special Income Charges,
POLYMED.NS,income,2021-03-31 00:00:00,Other Special Charges,-72000.0
POLYMED.NS,income,2021-03-31 00:00:00,Write Off,1799000.0
POLYMED.NS,income,2021-03-31 00:00:00,Net Non Operating Interest Income Expense,
POLYMED.NS,income,2021-03-31 00:00:00,Total Other Finance Cost,29028000.0
POLYMED.NS,income,2021-03-31 00:00:00,Interest Expense Non Operating,
POLYMED.NS,income,2021-03-31 00:00:00,Interest Income Non Operating,33726000.0
POLYMED.NS,income,2021-03-31 00:00:00,Operating Income,
POLYMED.NS,income,2021-03-31 00:00:00,Operating Expense,
POLYMED.NS,income,2021-03-31 00:00:00,Other Operating Expenses,
POLYMED.NS,income,2021-03-31 00:00:00,Depreciation And Amortization In Income Statement,
POLYMED.NS,income,2021-03-31 00:00:00,Amortization,24988000.0
POLYMED.NS,income,2021-03-31 00:00:00,Depreciation Income Statement,
POLYMED.NS,income,2021-03-31 00:00:00,Research And Development,
POLYMED.NS,income,2021-03-31 00:00:00,Selling General And Administration,294585000.0
POLYMED.NS,income,2021-03-31 00:00:00,Selling And Marketing Expense,126279000.0
POLYMED.NS,income,2021-03-31 00:00:00,General And Administrative Expense,168306000.0
POLYMED.NS,income,2021-03-31 00:00:00,Rent And Landing Fees,22191000.0
POLYMED.NS,income,2021-03-31 00:00:00,Gross Profit,
POLYMED.NS,income,2021-03-31 00:00:00,Cost Of Revenue,
POLYMED.NS,income,2021-03-31 00:00:00,Total Revenue,
POLYMED.NS,income,2021-03-31 00:00:00,Operating Revenue,
